查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1600662

避孕藥市場：按產品、性別、方法和分佈分類 - 全球預測 2025-2030

Contraceptive Market by Product (Devices, Drugs), Gender (Female Contraceptive, Male Contraceptive), Method, Distribution - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年避孕藥市場規模為484.3億美元，預計2024年將達到548.7億美元，複合年成長率為13.82%，2030年將達到1198.9億美元。

避孕市場包括各種旨在預防懷孕、管理生殖健康和對抗性性行為感染的產品和服務。該系列包括荷爾蒙避孕法（如避孕藥和注射避孕藥）、屏障避孕法（如保險套和隔膜）以及新技術（如子宮內避孕器 (IUD)、避孕植入和貼片）。世界對生殖健康權利、人口控制以及賦予婦女對計劃生育做出明智選擇的權利的日益關注，推動了對此類產品的需求。避孕藥具用途廣泛，可滿足臨時和長期需求，最終用途範圍從個人消費者到醫療保健提供者和有組織的分銷管道。

主要市場統計
基準年[2023] 484.3億美元
預測年份 [2024] 548.7億美元
預測年份 [2030] 1198.9億美元
複合年成長率（%） 13.82%

影響避孕市場的主要成長要素包括人們對生殖健康措施的認知和接受程度的提高、政府對計劃生育的宣傳活動以及導致更有效和方便的避孕方法的技術進步。潛在的機會存在於擴大避孕需求未被滿足的發展中地區的獲取，以及滿足已開發國家對更個性化且無副作用的選擇的需求。與政府和非政府組織的策略夥伴關係可以擴大市場範圍和滲透率。然而，由於社會和宗教阻力、潛在副作用、使用誤解以及區域監管挑戰，市場成長面臨限制。

成熟的研究創新領域包括開發男性避孕藥、減少女性副作用的非荷爾蒙選擇，以及提供個人化避孕建議的數位健康解決方案。避孕藥具市場是動態的，對文化、社會和經濟因素高度敏感。對市場行為的洞察表明，消費者的偏好正在轉向便利性、微創性和長期可靠性，這為投資這些創新的公司展現了巨大潛力。策略建議包括投資尖端解決方案的研發、加強消費者教育以及調整行銷策略以克服文化障礙和誤解。

市場動態：揭示快速發展的避孕市場的關鍵市場洞察

供需的動態交互作用正在改變避孕藥具市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 對性健康和計劃生育的認知不斷提高
    • 政府支持的鼓勵使用和提供避孕藥的舉措
  • 市場限制因素
    • 避孕產品對健康的不良影響
  • 市場機會
    • 透過廣泛的研究和開發引入負擔得起的避孕方法
    • 透過線上通路提供避孕藥具
  • 市場挑戰
    • 有關避孕藥具使用的社會關注和產品行銷問題

波特五力：駕馭避孕市場的策略工具

波特的五力框架是了解避孕市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解避孕藥市場的外部影響

外部宏觀環境因素對避孕藥具市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解避孕藥具市場的競爭格局

對避孕藥市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣避孕藥具市場供應商績效評估

FPNV定位矩陣是評估避孕藥具市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。四個象限清楚且準確地分類供應商，幫助使用者辨識最能滿足其策略目標的合作夥伴和解決方案。

本報告提供了涵蓋關鍵重點領域的全面市場分析：

1. 市場滲透率：對當前市場環境的詳細回顧，包括行業主要企業的大量資料。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 提高對性健康和計劃生育的認知
      • 政府支持措施鼓勵避孕藥的使用和提供
    • 抑制因素
      • 避孕產品對健康的不良影響
    • 機會
      • 透過廣泛的研究和開發介紹經濟實惠的避孕方法
      • 透過線上通路提供避孕器
    • 任務
      • 有關避孕藥具使用的社會關注和產品行銷問題
  • 市場區隔分析
    • 產品：由於易於使用和非侵入性，避孕藥物的高趨勢
    • 性別：由於產品種類繁多，女性用避孕器的採用率顯著增加。
    • 方法：屏障避孕法在性行為過程中提供物理和化學屏障，越來越受歡迎。
    • 分銷管道：網路藥局的24/7 服務增強了產品分銷。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 避孕藥市場：依產品

  • 裝置
    • 保險套
    • 隔膜
    • 子宮內避孕器
      • 含銅子宮內避孕器
      • 荷爾蒙子宮內避孕器
    • 皮下植入
    • 避孕環
  • 藥物
    • 注射
    • 口服錠劑
    • 經皮避孕貼劑

第7章 避孕藥市場性別

  • 女性避孕藥
  • 男性避孕藥

第8章避孕藥市場：依方法分類

  • 障礙
  • 和諧的

第9章 避孕藥具市場經銷商

  • 連鎖藥房
  • 診所
  • 政府網路
  • 醫院藥房
  • 獨立藥房
  • 網路平台

第10章美洲避孕藥市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太避孕市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲避孕市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 列治文生物科技公司斥資1億美元收購避孕藥業務
    • 英國開始首次試驗無荷爾蒙男性避孕藥
    • Aditxt 以 1 億美元收購 Phexxi 避孕凝膠製造商 Evofem
    • Dare Biosciences 開始無激素三期避孕試驗
    • Lupin 在美國推出 Turcoz（炔諾孕酮和炔雌醇）片劑 USP
    • 拜耳和 Crossbay Medical 開發新型子宮內系統插入器
    • Xiromed LLC 宣佈在美國推出 EnilloRing
    • 拜耳將在芬蘭建造新的 2.672 億美元生產設施，以促進全球採用現代避孕方法
    • NIH 中心津貼加強男性研究
    • 蓋茲基金會、兒童投資基金基金會、輝瑞和 BD 擴大合作夥伴關係，以擴大女性獲得注射的機會
    • Perrigo與美國FDA宣布核准OTC每日口服藥物「Opil」避孕藥
    • FDA核准首個非處方箋口服避孕藥
    • Sirona 收購印度首個純素保險套品牌 Blue

公司名單

  • Abbvie Inc.
  • Acme Generics Pvt. Ltd.
  • Afaxys, Inc.
  • Agile Therapeutics, Inc.
  • Amneal Pharmaceuticals LLC
  • ASKA Pharmaceutical Co., Ltd.
  • Aurobindo Pharma Limited
  • Bayer AG
  • Church & Dwight Co., Inc.
  • HLL Lifecare Limited
  • Insud Pharma, SL
  • Johnson & Johnson Services, Inc.
  • Lupin Limited
  • Mayne Pharma Group Limited
  • Merck & Co., Inc.
  • Mithra Pharmaceuticals SA
  • Okamoto Industries, Inc.
  • Organon & Co.
  • Perrigo Company plc
  • Pfizer Inc.
  • Piramal Pharma Ltd.
  • Reckitt Benckiser Group plc
  • RITEX GMBH
  • Sanofi SA
  • Say It With A Condom, LLC.
  • Syzygy Healthcare Solutions LLC
  • Teva Pharmaceutical Industries Ltd.
  • TherapeuticsMD, Inc.
  • TTK Healthcare Limited
  • Veru Inc.
  • Viatris Inc.
Product Code: MRR-4316E4E895C4

The Contraceptive Market was valued at USD 48.43 billion in 2023, expected to reach USD 54.87 billion in 2024, and is projected to grow at a CAGR of 13.82%, to USD 119.89 billion by 2030.

The contraceptive market encompasses a range of products and services aimed at preventing pregnancy, managing reproductive health, and addressing sexually transmitted infections. Its scope includes hormonal methods like pills and injectable contraceptives, barrier methods such as condoms and diaphragms, intrauterine devices (IUDs), and emerging technologies like contraceptive implants and patches. The necessity for such products is driven by the increasing global focus on reproductive health rights, population control, and the empowerment of women to make informed choices regarding family planning. The application of contraceptives is widespread, catering to both temporary and long-term needs of users, with end-use scopes stretching from individual consumers to healthcare providers and institutional distribution channels.

KEY MARKET STATISTICS
Base Year [2023] USD 48.43 billion
Estimated Year [2024] USD 54.87 billion
Forecast Year [2030] USD 119.89 billion
CAGR (%) 13.82%

Key growth factors influencing the contraceptive market include the rising awareness and acceptance of reproductive health measures, supportive governmental campaigns for family planning, and technological advancements leading to more efficient and convenient contraceptive methods. There are potential opportunities in expanding access in developing regions where unmet needs for contraceptives are high, as well as addressing the demand in developed countries for more personalized and side-effect-free options. Strategic partnerships with governmental and non-governmental organizations can enhance market reach and penetration. However, market growth faces limitations from societal and religious resistances, potential side effects and misconceptions about contraceptive use, and regulatory challenges in different regions.

Innovative areas ripe for research include the development of male contraceptives, non-hormonal options that reduce side effects for women, and digital health solutions that offer personalized contraceptive advice. The contraceptive market is dynamic and highly sensitive to cultural, social, and economic factors. Insights into market behavior suggest a consumer preference shift towards convenience, minimal invasiveness, and long-term reliability, indicating significant potential for companies investing in these innovations. Strategic recommendations include investing in R&D for cutting-edge solutions, enhancing consumer education, and tailoring marketing strategies to overcome cultural barriers and misconceptions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Contraceptive Market

The Contraceptive Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increased awareness regarding sexual health and family planning
    • Supportive government initiatives to encourage use and provision of contraceptive pills
  • Market Restraints
    • Adverse health impacts of contraceptive products
  • Market Opportunities
    • Introduction of affordable contraceptive methods with extensive R&D
    • Availability of contraceptives through online distribution channels
  • Market Challenges
    • Social concerns regarding contraceptive usage and issues with product marketing

Porter's Five Forces: A Strategic Tool for Navigating the Contraceptive Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Contraceptive Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Contraceptive Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Contraceptive Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Contraceptive Market

A detailed market share analysis in the Contraceptive Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Contraceptive Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Contraceptive Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Contraceptive Market, highlighting leading vendors and their innovative profiles. These include Abbvie Inc., Acme Generics Pvt. Ltd., Afaxys, Inc., Agile Therapeutics, Inc., Amneal Pharmaceuticals LLC, ASKA Pharmaceutical Co., Ltd., Aurobindo Pharma Limited, Bayer AG, Church & Dwight Co., Inc., HLL Lifecare Limited, Insud Pharma, S.L., Johnson & Johnson Services, Inc., Lupin Limited, Mayne Pharma Group Limited, Merck & Co., Inc., Mithra Pharmaceuticals S.A., Okamoto Industries, Inc., Organon & Co., Perrigo Company plc, Pfizer Inc., Piramal Pharma Ltd., Reckitt Benckiser Group plc, RITEX GMBH, Sanofi S.A., Say It With A Condom, LLC., Syzygy Healthcare Solutions LLC, Teva Pharmaceutical Industries Ltd., TherapeuticsMD, Inc., TTK Healthcare Limited, Veru Inc., and Viatris Inc..

Market Segmentation & Coverage

This research report categorizes the Contraceptive Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Devices and Drugs. The Devices is further studied across Condoms, Diaphragm, IUDs, Subdermal Implants, and Vaginal Rings. The IUDs is further studied across Copper IUDs and Hormonal IUDs. The Drugs is further studied across Injectables, Oral Contraceptive Pills, and Transdermal Contraceptive Patch.
  • Based on Gender, market is studied across Female Contraceptive and Male Contraceptive.
  • Based on Method, market is studied across Barrier and Harmonal.
  • Based on Distribution, market is studied across Chain Pharmacy, Clinics, Government Network, Hospital Pharmacy, Independent Pharmacy, and Online Platform.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increased awareness regarding sexual health and family planning
      • 5.1.1.2. Supportive government initiatives to encourage use and provision of contraceptive pills
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse health impacts of contraceptive products
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of affordable contraceptive methods with extensive R&D
      • 5.1.3.2. Availability of contraceptives through online distribution channels
    • 5.1.4. Challenges
      • 5.1.4.1. Social concerns regarding contraceptive usage and issues with product marketing
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: High inclination toward contraceptive drugs due to their ease of use and non-invasiveness
    • 5.2.2. Gender: Significant adoption of female contraceptives due to availability of a wide range of products
    • 5.2.3. Method: Rising preference for barrier methods of contraception that provide a physical and chemical barrier during sexual activities
    • 5.2.4. Distribution Channel: Enhanced product distribution through online pharmacies due to their 24/7 services
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Contraceptive Market, by Product

  • 6.1. Introduction
  • 6.2. Devices
    • 6.2.1. Condoms
    • 6.2.2. Diaphragm
    • 6.2.3. IUDs
      • 6.2.3.1. Copper IUDs
      • 6.2.3.2. Hormonal IUDs
    • 6.2.4. Subdermal Implants
    • 6.2.5. Vaginal Rings
  • 6.3. Drugs
    • 6.3.1. Injectables
    • 6.3.2. Oral Contraceptive Pills
    • 6.3.3. Transdermal Contraceptive Patch

7. Contraceptive Market, by Gender

  • 7.1. Introduction
  • 7.2. Female Contraceptive
  • 7.3. Male Contraceptive

8. Contraceptive Market, by Method

  • 8.1. Introduction
  • 8.2. Barrier
  • 8.3. Harmonal

9. Contraceptive Market, by Distribution

  • 9.1. Introduction
  • 9.2. Chain Pharmacy
  • 9.3. Clinics
  • 9.4. Government Network
  • 9.5. Hospital Pharmacy
  • 9.6. Independent Pharmacy
  • 9.7. Online Platform

10. Americas Contraceptive Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Contraceptive Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Contraceptive Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Richmond Biotech Company to buy Contraceptive biz for USD 100 Million
    • 13.3.2. UK Launches First Trial of Hormone-free Male Birth Control pill
    • 13.3.3. Aditxt Acquires Phexxi Contraceptive Gel-Maker Evofem for USD 100 million
    • 13.3.4. Dare Bioscience Launches Phase III Hormone-free Contraceptive Trial
    • 13.3.5. Lupin Launches Turqoz (Norgestrel and Ethinyl Estradiol) Tablets USP in the United States
    • 13.3.6. Bayer and CrossBay Medical to Develop Novel Intrauterine System Inserter
    • 13.3.7. Xiromed LLC Announces Launch of EnilloRing in the United States
    • 13.3.8. Bayer Invests in USD 267.2 Million new Production Facility in Finland to Accelerate Global Access to Modern Contraception
    • 13.3.9. NIH Center Grant Bolsters Male Contraceptive Research
    • 13.3.10. Gates Foundation, Children's Investment Fund Foundation, Pfizer and BD Company Expand Partnership for Greater Access to Injectable Contraceptive for Women
    • 13.3.11. Perrigo Announces U.S. FDA Approval for Opill OTC Daily Oral Contraceptive
    • 13.3.12. FDA Approves First Nonprescription Daily Oral Contraceptive
    • 13.3.13. Sirona Acquires India's First Vegan Condom Brand Bleu

Companies Mentioned

  • 1. Abbvie Inc.
  • 2. Acme Generics Pvt. Ltd.
  • 3. Afaxys, Inc.
  • 4. Agile Therapeutics, Inc.
  • 5. Amneal Pharmaceuticals LLC
  • 6. ASKA Pharmaceutical Co., Ltd.
  • 7. Aurobindo Pharma Limited
  • 8. Bayer AG
  • 9. Church & Dwight Co., Inc.
  • 10. HLL Lifecare Limited
  • 11. Insud Pharma, S.L.
  • 12. Johnson & Johnson Services, Inc.
  • 13. Lupin Limited
  • 14. Mayne Pharma Group Limited
  • 15. Merck & Co., Inc.
  • 16. Mithra Pharmaceuticals S.A.
  • 17. Okamoto Industries, Inc.
  • 18. Organon & Co.
  • 19. Perrigo Company plc
  • 20. Pfizer Inc.
  • 21. Piramal Pharma Ltd.
  • 22. Reckitt Benckiser Group plc
  • 23. RITEX GMBH
  • 24. Sanofi S.A.
  • 25. Say It With A Condom, LLC.
  • 26. Syzygy Healthcare Solutions LLC
  • 27. Teva Pharmaceutical Industries Ltd.
  • 28. TherapeuticsMD, Inc.
  • 29. TTK Healthcare Limited
  • 30. Veru Inc.
  • 31. Viatris Inc.

LIST OF FIGURES

  • FIGURE 1. CONTRACEPTIVE MARKET RESEARCH PROCESS
  • FIGURE 2. CONTRACEPTIVE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CONTRACEPTIVE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CONTRACEPTIVE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CONTRACEPTIVE MARKET SIZE, BY GENDER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CONTRACEPTIVE MARKET SIZE, BY GENDER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CONTRACEPTIVE MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CONTRACEPTIVE MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. CONTRACEPTIVE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. CONTRACEPTIVE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CONTRACEPTIVE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CONTRACEPTIVE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CONTRACEPTIVE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CONTRACEPTIVE MARKET DYNAMICS
  • TABLE 7. GLOBAL CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CONTRACEPTIVE MARKET SIZE, BY CONDOMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DIAPHRAGM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CONTRACEPTIVE MARKET SIZE, BY IUDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CONTRACEPTIVE MARKET SIZE, BY COPPER IUDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CONTRACEPTIVE MARKET SIZE, BY HORMONAL IUDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CONTRACEPTIVE MARKET SIZE, BY SUBDERMAL IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CONTRACEPTIVE MARKET SIZE, BY VAGINAL RINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CONTRACEPTIVE MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CONTRACEPTIVE MARKET SIZE, BY ORAL CONTRACEPTIVE PILLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CONTRACEPTIVE MARKET SIZE, BY TRANSDERMAL CONTRACEPTIVE PATCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CONTRACEPTIVE MARKET SIZE, BY FEMALE CONTRACEPTIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CONTRACEPTIVE MARKET SIZE, BY MALE CONTRACEPTIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CONTRACEPTIVE MARKET SIZE, BY BARRIER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CONTRACEPTIVE MARKET SIZE, BY HARMONAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CONTRACEPTIVE MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CONTRACEPTIVE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CONTRACEPTIVE MARKET SIZE, BY GOVERNMENT NETWORK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CONTRACEPTIVE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CONTRACEPTIVE MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL CONTRACEPTIVE MARKET SIZE, BY ONLINE PLATFORM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 94. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 101. CHINA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 107. INDIA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 108. INDIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 114. INDONESIA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 115. INDONESIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 121. JAPAN CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 122. JAPAN CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 128. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 129. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 136. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 142. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 143. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 149. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 150. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 156. TAIWAN CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 157. TAIWAN CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 163. THAILAND CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 164. THAILAND CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 170. VIETNAM CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 171. VIETNAM CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 185. DENMARK CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 186. DENMARK CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 192. EGYPT CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 193. EGYPT CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 199. FINLAND CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 200. FINLAND CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 206. FRANCE CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 207. FRANCE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 213. GERMANY CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 214. GERMANY CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 220. ISRAEL CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 221. ISRAEL CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 227. ITALY CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 228. ITALY CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 234. NETHERLANDS CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 235. NETHERLANDS CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 241. NIGERIA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 242. NIGERIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 248. NORWAY CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 249. NORWAY CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 255. POLAND CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 256. POLAND CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 262. QATAR CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 263. QATAR CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 269. RUSSIA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 270. RUSSIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 276. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 277. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH AFRICA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 284. SOUTH AFRICA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 285. SPAIN CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 290. SPAIN CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 291. SPAIN CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 292. SWEDEN CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 297. SWEDEN CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 298. SWEDEN CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 299. SWITZERLAND CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 304. SWITZERLAND CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 305. SWITZERLAND CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 306. TURKEY CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 307. TURKEY CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 310. TURKEY CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 311. TURKEY CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 312. TURKEY CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 313. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 314. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
  • TABLE 323. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 324. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 325. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 326. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 327. CONTRACEPTIVE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 328. CONTRACEPTIVE MARKET, FPNV POSITIONING MATRIX, 2023